US › Healthcare

Heartbeam Inc (BEAT)

US · Healthcare · Health Information Services

$0.50+0.98%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-4.7M
Profit YoY
+14.3%
EPS
$-0.12
EPS estimate
$-0.13

EPS came in at -0.12 against a street estimate of -0.13 — a beat of 7.7%.

Key statistics

Market cap
$27.3M
Forward P/E
0.0
P/B
43.76
Book value
$0.01
EPS (TTM)
$-0.56
52-week high
$4.00
52-week low
$0.48
50-day MA
$0.71
200-day MA
$1.30
Beta
-0.79

Analyst view

Analysts rate Heartbeam Inc a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $3.38.

Shareholding

Insiders
19.86%
Institutions
9.30%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC2.16%
BlackRock Inc1.62%
Geode Capital Management, LLC0.68%
Smith, Salley & Associates, LLC0.66%
UBS Group AG0.60%
Beacon Pointe Advisors, LLC0.45%
Comprehensive Portfolio Management, LLC0.38%
O'Shaughnessy Asset Management LLC0.38%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Heartbeam Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.